SCIEX Announces New Integration for its Echo MS+ System

SCIEX’s Echo MS+ system, a high-throughput analytical solution, is now compatible with the ZenoTOF 8600 system, an accurate mass spectrometer recognized for enhanced sensitivity, the company reported. The integration reportedly provides the industry’s highest-throughput, accurate mass platform.

For labs operating on an elevated analytical scale and requiring direct physical measurement across a wide array of compounds, this integration provides access to assays previously not available with conventional mass spectrometry, according to SCIEX.

Key differentiators include:

• Deliver reliable, high-quality data with direct, label-free measurement through mass spectrometry.
• Contactless ejection removes the potential for carryover, using as little as 2.5 nL of sample.
• Enhance efficiency with minimized sample preparation and a sampling rate of up to one sample per second. The system is also able to couple with front-end automation.

“The enhanced sensitivity allows researchers to work with significantly smaller protein quantities and delivers substantial cost efficiencies throughout the drug‑development process,” said Susan Darling, Senior Director, Adjacent & Transformational Technologies, SCIEX.

This integration adds to the existing compatibility of the Echo MS+ system with the SCIEX Triple Quad 6500+ system and the ZenoTOF 7600 system.

SCIEX, a Danaher company and leader in life science analytical technologies, empowers customers to solve impactful analytical challenges in quantitation and characterization. Since the launch of the first-ever commercially successful triple quadrupole in 1981, SCIEX continues to develop technologies and solutions that influence research and outcomes.

Danaher is a global life sciences and diagnostics innovator, accelerating the power of science and technology to improve human health. Its businesses partner closely with customers to solve many of the most important health challenges impacting patients worldwide. Danaher’s advanced science and technology help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop, and deliver therapies. Focused on scientific excellence, innovation, and continuous improvement, the company’s approximately 63,000 associates worldwide help ensure that Danaher is improving the quality of life for people today, while setting the foundation for a healthier, more sustainable tomorrow.